Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
PLUS THERAPEUTICS, Inc. Common Stock (PSTV)
Surgical & Medical Instruments & Apparatus
https://www.plustherapeutics.com
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.
4200 MARATHON BLVD., SUITE 200
AUSTIN, TX
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
11/16/2000
Market Cap
7,985,908
Shares Outstanding
4,520,000
Weighted SO
4,522,656
Total Employees
N/A
Upcoming Earnings
08/12/2024
Beta
0.5370
Last Div
0.0000
Range
0.97-3.21
Chg
0.0100
Avg Vol
56225
Mkt Cap
7985908
Exch
NASDAQ
Country
US
Phone
737 255 7194
DCF Diff
-3.7755
DCF
5.8254
Div Yield
0.0000
P/S
1.4496
EV Multiple
-0.4940
P/FV
-1.1936
Div Yield %
0.0000
P/E
-0.6879
PEG
-0.0107
Payout
0.0000
Current Ratio
0.4993
Quick Ratio
0.4993
Cash Ratio
0.2615
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
3344.7098
CCC
-3344.7098
Gross Margin
0.8624
Op Margin
-2.5607
Pretax Margin
-2.4015
Net Margin
-2.4015
Eff Tax Rate
-0.0302
ROA
-1.1800
ROE
4.7301
ROCE
1.8623
NI/EBT
1.0000
EBT/EBIT
0.9378
EBIT/Rev
-2.5607
Debt Ratio
0.3063
D/E
-0.4504
LT Debt/Cap
-0.0066
Total Debt/Cap
-0.8194
Int Coverage
-90.4295
CF/Debt
-2.8955
Equity Multi
-1.4704
Rec Turnover
0.0000
Pay Turnover
0.1091
Inv Turnover
0.0000
FA Turnover
6.3249
Asset Turnover
0.4913
OCF/Share
-1.5295
FCF/Share
-1.6399
Cash/Share
1.2975
OCF/Sales
-1.8049
FCF/OCF
1.0722
CF Coverage
-2.8955
ST Coverage
-2.9382
CapEx Coverage
-13.8482
Div&CapEx Cov
-13.8482
P/BV
-1.1936
P/B
-1.1936
P/S
1.4496
P/E
-0.6879
P/FCF
-0.7491
P/OCF
-0.9153
P/CF
-0.9153
PEG
-0.0107
P/S
1.4496
EV Multiple
-0.4940
P/FV
-1.1936
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
661.12K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
301.80K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 2.14M | ▼ 1.19M | ▼ 0.00 | 0.00 | ▲ 224.00K | ▲ 1.31M | ▲ 1.68M |
Cost Of Revenue | 230.00K | ▲ 353.00K | ▲ 1.10M | ▼ 117.00K | ▲ 287.00K | ▼ 182.00K | ▲ 186.00K |
Gross Profit | 1.91M | ▼ 835.00K | ▼ -1.10M | ▲ -117.00K | ▲ -63.00K | ▲ 1.13M | ▲ 1.49M |
Gross Profit Ratio | 0.89 | ▼ 0.70 | ▼ 0.00 | 0.00 | ▼ -0.28 | ▲ 0.86 | ▲ 0.89 |
Research And Development Expenses | 2.26M | ▼ 1.73M | ▼ 1.10M | ▲ 1.85M | ▲ 2.14M | ▲ 2.79M | ▼ 2.76M |
General And Administrative Expenses | 1.14M | ▲ 1.52M | ▲ 2.61M | ▼ 2.04M | ▲ 3.59M | ▼ 2.38M | ▼ 2.21M |
Selling And Marketing Expenses | 362.00K | ▼ 152.00K | ▼ -314.00K | ▲ 0.00 | 0.00 | ▼ -182.00K | ▼ -186.00K |
Selling General And Administrative Expenses | 1.50M | ▲ 1.67M | ▲ 2.30M | ▼ 2.04M | ▲ 3.59M | ▼ 2.20M | ▼ 2.03M |
Other Expenses | 23.00K | ▼ -306.00K | ▲ 781.00K | ▼ 316.00K | ▼ 73.00K | ▼ 0.00 | 0.00 |
Operating Expenses | 4.06M | ▼ 3.40M | ▼ 3.40M | ▲ 3.89M | ▲ 5.80M | ▼ 4.99M | ▼ 4.79M |
Cost And Expenses | 4.29M | ▼ 3.40M | ▼ 3.40M | ▲ 3.89M | ▲ 5.80M | ▼ 5.17M | ▼ 4.98M |
Interest Income | 13.00K | ▲ 35.00K | ▼ 3.00K | ▲ 6.00K | ▲ 73.00K | ▲ 110.00K | ▼ 72.00K |
Interest Expense | 543.00K | ▼ 378.00K | ▼ 253.00K | ▼ 224.00K | ▼ 159.00K | ▼ 62.00K | ▼ 34.00K |
Depreciation And Amortization | 539.00K | ▼ 118.00K | ▼ 93.00K | ▲ 129.00K | ▲ 232.00K | ▼ 182.00K | ▲ 186.00K |
Ebitda | -1.58M | ▼ -2.06M | ▼ -3.30M | ▼ -3.75M | ▼ -5.34M | ▲ -3.68M | ▲ -3.11M |
Ebitda Ratio | -0.74 | ▼ -1.73 | ▲ 0.00 | 0.00 | ▼ -23.84 | ▲ -2.80 | ▲ -1.86 |
Operating Income | -3.84M | ▲ -2.21M | ▼ -3.40M | ▼ -3.94M | ▼ -5.57M | ▲ -3.86M | ▲ -3.30M |
Operating Income Ratio | -1.80 | ▼ -1.86 | ▲ 0.00 | 0.00 | ▼ -24.88 | ▲ -2.94 | ▲ -1.97 |
Total Other Income Expenses Net | 453.00K | ▲ 3.48M | ▼ 58.00K | ▼ -46.00K | ▼ -86.00K | ▲ 50.00K | ▼ 38.00K |
Income Before Tax | -2.24M | ▲ 920.00K | ▼ -3.59M | ▼ -4.16M | ▼ -5.66M | ▲ -3.81M | ▲ -3.26M |
Income Before Tax Ratio | -1.05 | ▲ 0.77 | ▼ 0.00 | 0.00 | ▼ -25.26 | ▲ -2.90 | ▲ -1.94 |
Income Tax Expense | 566.00K | ▼ -6.88M | ▲ 253.00K | ▼ 224.00K | ▼ 86.00K | ▼ 0.00 | 0.00 |
Net Income | -2.24M | ▲ 884.00K | ▼ -3.59M | ▼ -4.16M | ▼ -5.74M | ▲ -3.81M | ▲ -3.26M |
Net Income Ratio | -1.05 | ▲ 0.74 | ▼ 0.00 | 0.00 | ▼ -25.64 | ▲ -2.90 | ▲ -1.94 |
Eps | -113.08 | ▲ 3.42 | ▼ -10.02 | ▲ -4.05 | ▲ -2.56 | ▲ -0.84 | ▲ -0.75 |
Eps Diluted | -113.08 | ▲ 3.42 | ▼ -10.02 | ▲ -4.03 | ▲ -2.56 | ▲ -0.84 | ▲ -0.75 |
Weighted Average Shs Out | 19.77K | ▲ 258.71K | ▲ 357.97K | ▲ 1.03M | ▲ 2.24M | ▲ 4.52M | ▼ 4.32M |
Weighted Average Shs Out Dil | 19.77K | ▲ 258.71K | ▲ 357.97K | ▲ 1.03M | ▲ 2.24M | ▲ 4.52M | ▼ 4.32M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 5.26M | ▲ 17.55M | ▼ 8.35M | ▲ 18.40M | ▼ 18.12M | ▼ 8.55M | ▼ 2.90M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 323.00K |
Cash And Short Term Investments | 5.26M | ▲ 17.55M | ▼ 8.35M | ▲ 18.40M | ▼ 18.12M | ▼ 8.55M | ▼ 3.22M |
Net Receivables | 377.00K | ▲ 1.31M | ▼ 59.00K | ▼ 7.00K | ▼ 0.00 | 0.00 | 0.00 |
Inventory | 2.95M | ▼ 107.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 1.06M | ▼ 853.00K | ▼ 770.00K | ▲ 1.32M | ▲ 3.70M | ▼ 1.28M | ▼ 989.00K |
Total Current Assets | 9.65M | ▲ 19.83M | ▼ 9.18M | ▲ 19.72M | ▲ 21.82M | ▼ 9.83M | ▼ 4.21M |
Property Plant Equipment Net | 2.56M | ▲ 2.96M | ▼ 2.46M | ▼ 1.82M | ▼ 1.57M | ▼ 1.11M | ▼ 971.00K |
Goodwill | 3.92M | ▼ 372.00K | 372.00K | 372.00K | 372.00K | 372.00K | 372.00K |
Intangible Assets | 5.96M | ▼ 0.00 | ▲ 86.00K | ▼ 51.00K | ▲ 94.00K | ▼ 42.00K | ▼ 33.00K |
Goodwill And Intangible Assets | 9.88M | ▼ 372.00K | ▲ 458.00K | ▼ 423.00K | ▲ 466.00K | ▼ 414.00K | ▼ 405.00K |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 1.91M | ▼ 72.00K | ▼ 16.00K | 16.00K | ▼ 12.00K | ▲ 32.00K | 32.00K |
Total Non Current Assets | 14.34M | ▼ 3.40M | ▼ 2.93M | ▼ 2.26M | ▼ 2.05M | ▼ 1.55M | ▼ 1.41M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 23.99M | ▼ 23.23M | ▼ 12.11M | ▲ 21.98M | ▲ 23.87M | ▼ 11.39M | ▼ 5.62M |
Account Payables | 720.00K | ▼ 327.00K | ▲ 789.00K | ▲ 2.61M | ▲ 8.36M | ▼ 4.76M | ▲ 6.45M |
Short Term Debt | 14.20M | ▼ 11.33M | ▼ 6.47M | ▼ 1.72M | ▼ 1.72M | ▲ 4.10M | ▼ 3.71M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 167.00K | ▲ 2.83M | ▼ 1.26M | ▲ 1.42M | ▼ 0.00 | 0.00 | ▲ 247.00K |
Other Current Liabilities | 2.47M | ▼ 6.00K | ▲ 23.00K | ▲ 122.00K | ▲ 1.77M | ▲ 1.87M | ▼ 0.00 |
Total Current Liabilities | 17.56M | ▼ 14.49M | ▼ 8.54M | ▼ 5.87M | ▲ 11.85M | ▼ 10.73M | ▼ 10.40M |
Long Term Debt | 0.00 | ▲ 646.00K | ▼ 528.00K | ▲ 5.27M | ▼ 3.93M | ▼ 85.00K | ▼ 59.00K |
Deferred Revenue Non Current | 167.00K | ▼ 0.00 | 0.00 | 0.00 | ▲ 1.64M | ▲ 1.92M | ▼ 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.64M | ▼ -1.92M | ▲ 0.00 |
Other Non Current Liabilities | 1.04M | ▲ 6.94M | ▼ 7.00K | ▼ 1.00K | ▲ 1.64M | ▲ 1.92M | ▼ 0.00 |
Total Non Current Liabilities | 1.21M | ▲ 7.58M | ▼ 535.00K | ▲ 5.28M | ▲ 5.57M | ▼ 2.01M | ▼ 59.00K |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | ▲ 913.00K | ▼ 661.00K | ▼ 380.00K | ▼ 251.00K | ▼ 85.00K | ▼ 59.00K |
Total Liabilities | 18.77M | ▲ 22.07M | ▼ 9.07M | ▲ 11.15M | ▲ 17.42M | ▼ 12.74M | ▼ 10.46M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 15.00K | ▼ 4.00K | ▲ 7.00K | ▲ 16.00K | ▲ 34.00K | ▼ 5.00K | 5.00K |
Retained Earnings | -414.38M | ▼ -425.27M | ▼ -433.51M | ▼ -446.91M | ▼ -467.19M | ▼ -480.50M | ▼ -483.76M |
Accumulated Other Comprehensive Income Loss | 1.22M | ▼ -1.02M | ▼ -1.39M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 418.38M | ▲ 427.45M | ▲ 437.92M | ▲ 457.73M | ▲ 473.60M | ▲ 479.15M | ▼ 478.92M |
Total Stockholders Equity | 5.23M | ▼ 1.16M | ▲ 3.03M | ▲ 10.84M | ▼ 6.45M | ▼ -1.35M | ▼ -4.84M |
Total Equity | 5.23M | ▼ 1.16M | ▲ 3.03M | ▲ 10.84M | ▼ 6.45M | ▼ -1.35M | ▼ -4.84M |
Total Liabilities And Stockholders Equity | 23.99M | ▼ 23.23M | ▼ 12.11M | ▲ 21.98M | ▲ 23.87M | ▼ 11.39M | ▼ 5.62M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 23.99M | ▼ 23.23M | ▼ 12.11M | ▲ 21.98M | ▲ 23.87M | ▼ 11.39M | ▼ 5.62M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 323.00K |
Total Debt | 14.20M | ▼ 11.97M | ▼ 7.00M | ▼ 6.99M | ▼ 5.65M | ▼ 4.18M | ▼ 3.76M |
Net Debt | 8.94M | ▼ -5.58M | ▲ -1.35M | ▼ -11.41M | ▼ -12.48M | ▲ -4.37M | ▲ 863.00K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -2.24M | ▲ 884.00K | ▼ -3.59M | ▼ -4.16M | ▼ -5.66M | ▲ -3.81M | ▲ -3.26M |
Depreciation And Amortization | 539.00K | ▼ 118.00K | ▼ 93.00K | ▲ 129.00K | ▲ 159.00K | ▲ 182.00K | ▲ 186.00K |
Deferred Income Tax | -496.00K | ▼ -3.27M | ▲ 49.00K | ▼ 46.00K | ▼ 0.00 | ▼ -121.00K | ▲ 0.00 |
Stock Based Compensation | 30.00K | ▼ 21.00K | ▲ 98.00K | ▲ 181.00K | ▼ 130.00K | ▲ 141.00K | ▲ 146.00K |
Change In Working Capital | -647.00K | ▲ 3.10M | ▼ -34.00K | ▲ 808.00K | ▲ 2.93M | ▼ 1.58M | ▼ -1.60M |
Accounts Receivables | 143.00K | ▲ 3.65M | ▼ 1.09M | ▼ 0.00 | ▼ -73.00K | ▲ 91.00K | ▼ 0.00 |
Inventory | -140.00K | ▲ -15.00K | ▲ 107.00K | ▼ 0.00 | ▲ 73.00K | ▼ -91.00K | ▲ 0.00 |
Accounts Payables | 109.00K | ▼ -28.00K | ▼ -1.23M | ▲ 1.73M | ▲ 4.93M | ▼ 384.00K | ▼ -43.00K |
Other Working Capital | -759.00K | ▲ -504.00K | ▲ 4.00K | ▼ -926.00K | ▼ -2.00M | ▲ 1.19M | ▼ -1.56M |
Other Non Cash Items | 322.00K | ▼ 186.00K | ▼ 157.00K | ▲ 367.00K | ▼ 208.00K | ▼ 151.00K | ▲ 578.00K |
Net Cash Provided By Operating Activities | -2.49M | ▲ 1.04M | ▼ -3.22M | ▲ -2.62M | ▲ -2.23M | ▲ -1.88M | ▼ -4.51M |
Investments In Property Plant And Equipment | -5.00K | ▼ -59.00K | ▲ -56.00K | ▲ -10.00K | ▼ -11.00K | ▼ -42.00K | ▲ -40.00K |
Acquisitions Net | 0.00 | ▲ 2.85M | ▼ 0.00 | ▲ 12.00K | ▼ 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -324.00K |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -133.00K | ▲ 2.85M | ▼ 0.00 | ▲ 12.00K | ▲ 117.00K | ▼ 0.00 | ▼ -324.00K |
Net Cash Used For Investing Activities | -5.00K | ▲ 2.79M | ▼ -56.00K | ▲ 2.00K | ▼ -11.00K | ▼ -42.00K | ▼ -364.00K |
Debt Repayment | 0.00 | ▼ -3.11M | ▲ -24.00K | ▼ -268.00K | ▼ -402.00K | -402.00K | -402.00K |
Common Stock Issued | 0.00 | 0.00 | ▲ 4.01M | ▼ 10.00K | ▲ 501.00K | ▼ 347.00K | ▼ 0.00 |
Common Stock Repurchased | 0.00 | ▼ -1.00K | ▲ 0.00 | 0.00 | 0.00 | ▼ -474.00K | ▲ -374.00K |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 922.00K | ▼ -1.00K | ▲ 17.00K | ▼ 10.00K | ▲ 99.00K | ▼ -1.00K | ▲ 0.00 |
Net Cash Used Provided By Financing Activities | 922.00K | ▼ -3.11M | ▲ 4.00M | ▼ -258.00K | ▲ 99.00K | ▼ -529.00K | ▼ -776.00K |
Effect Of Forex Changes On Cash | 26.00K | ▼ 4.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash | -1.55M | ▲ 718.00K | ▲ 720.00K | ▼ -2.88M | ▲ -2.15M | ▼ -2.45M | ▼ -5.65M |
Cash At End Of Period | 5.30M | ▲ 17.59M | ▼ 8.35M | ▲ 18.40M | ▼ 18.12M | ▼ 8.55M | ▼ 2.90M |
Cash At Beginning Of Period | 6.85M | ▲ 16.87M | ▼ 7.63M | ▲ 21.28M | ▼ 20.27M | ▼ 11.01M | ▼ 8.55M |
Operating Cash Flow | -2.49M | ▲ 1.04M | ▼ -3.22M | ▲ -2.62M | ▲ -2.23M | ▲ -1.88M | ▼ -4.51M |
Capital Expenditure | -5.00K | ▼ -59.00K | ▲ -56.00K | ▲ -10.00K | ▼ -11.00K | ▼ -42.00K | ▲ -40.00K |
Free Cash Flow | -2.49M | ▲ 977.00K | ▼ -3.28M | ▲ -2.63M | ▲ -2.25M | ▲ -1.92M | ▼ -4.55M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)